Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1086 | 1030 | 1186 | 942 | 1127 | 1562 |
Fund Return | 8.58% | 3.02% | 18.65% | -1.98% | 2.42% | 4.56% |
Place in category | 1178 | 484 | 891 | 2548 | 1546 | 256 |
% in Category | 36 | 16 | 28 | 88 | 68 | 26 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
R Valor C EUR | 5.61B | 15.70 | 6.49 | 8.37 | ||
R Valor D EUR | 5.61B | 15.70 | 6.49 | 8.38 | ||
R Valor F EUR | 5.61B | 15.36 | 6.12 | 7.91 | ||
R Valor P EUR | 5.61B | 16.18 | 7.03 | 8.84 | ||
R Mines dOr | 228.55M | 32.74 | 9.13 | 10.33 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
R Valor F EUR | 5.61B | 15.36 | 6.12 | 7.91 | ||
R Valor P EUR | 5.61B | 16.18 | 7.03 | 8.84 | ||
R Valor C EUR | 5.61B | 15.70 | 6.49 | 8.37 | ||
R Valor D EUR | 5.61B | 15.70 | 6.49 | 8.38 | ||
CPR Croissance Reactive P | 1.1B | 4.66 | 0.52 | 2.22 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Prévoir Gestion Actions I | FR0011646454 | 19.83 | 2,751.780 | -0.53% | |
Morgan Stanley Investment Funds US Advantage Fund | LU0225741247 | 19.01 | 156.410 | -2.60% | |
Lazard Convertible Global A | FR0000098683 | 18.84 | 1,845.270 | -0.28% | |
Morgan Stanley Investment Funds - Asia Opportunity | LU1378878604 | 16.66 | 56.340 | -0.44% | |
Schroder International Selection Fund Global Clima | LU0302447452 | 15.32 | 34.879 | +1.00% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review